HNGR · Hanger, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $312.03M | $261.29M | - | $289.83M | $280.82M | $237.47M | - | $256.64M | $233.43M | $233.74M |
| Cost of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - | - | - | - | - |
| R&D | - | - | - | - | - | - | - | - | - | - |
| SG&A | $35.44M | $32.44M | - | $29.62M | $33.18M | $30.94M | - | $31.37M | $31.87M | $28.37M |
| Total Operating Expenses | - | - | - | - | - | - | - | - | - | - |
| D&A | - | - | - | - | - | - | - | $7.00M | $7.10M | $7.30M |
| Operating Income | $20.79M | ($2.54M) | - | $25.67M | $20.09M | $2.02M | - | $13.07M | $38.86M | ($9.17M) |
| Interest Expense | - | - | - | - | - | - | - | - | - | - |
| Income Tax | $2.99M | ($2.11M) | - | ($2.93M) | $2.62M | ($2.16M) | - | ($1.91M) | ($987.0K) | ($1.85M) |
| Net Income | $10.12M | ($7.98M) | - | $21.12M | $10.16M | ($3.33M) | - | $6.82M | $31.05M | ($15.75M) |
| EPS - Basic | $0.26 | ($0.21) | - | $0.55 | $0.26 | ($0.09) | - | $0.18 | $0.82 | - |
| EPS - Diluted | $0.26 | ($0.09) | - | $0.54 | $0.26 | - | - | $0.18 | $0.81 | - |
Balance Sheet
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $24.38M | $37.42M | $61.69M | $75.59M | $76.18M | $70.32M | $144.60M | $147.51M | $129.85M | $115.95M |
| Accounts Receivable | $150.90M | $139.62M | $152.06M | $136.11M | $124.96M | $118.16M | $128.60M | $121.41M | $115.58M | $128.88M |
| Inventory | $88.02M | $83.29M | $87.46M | $84.75M | $83.96M | $78.62M | $76.43M | $74.11M | $65.15M | $67.25M |
| Accounts Payable | $67.65M | $57.97M | $63.56M | $61.72M | $58.40M | $51.00M | $65.09M | $63.63M | $51.45M | $47.19M |
| Current Assets | $282.91M | $279.40M | $318.33M | $321.48M | $314.63M | $295.45M | $374.87M | $363.46M | $331.73M | $332.19M |
| Total Assets | $966.87M | $959.66M | $998.14M | $942.73M | $931.64M | $894.57M | $950.75M | $952.68M | $929.98M | $869.19M |
| Current Liabilities | $230.56M | $200.31M | $226.81M | $210.81M | $220.83M | $195.23M | $245.58M | $260.30M | $226.64M | $169.07M |
| Long-term Debt | - | - | - | - | - | - | - | - | - | - |
| Total Liabilities | $841.66M | $851.11M | $887.97M | $853.21M | $867.75M | $845.33M | $899.77M | $920.38M | $909.13M | $885.19M |
| Stockholders' Equity | $125.21M | $108.55M | $110.17M | $89.52M | $63.89M | $49.24M | $50.98M | $32.30M | $20.85M | ($16.00M) |
| Retained Earnings | ($249.88M) | ($259.99M) | ($252.02M) | ($266.05M) | ($287.17M) | ($297.33M) | ($294.00M) | ($310.07M) | ($316.88M) | ($347.94M) |
Cash Flow
| Line item | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | - | ($8.30M) | - | - | - | ($42.37M) | - | - | - | ($21.97M) |
| Investing Cash Flow | - | ($7.90M) | - | - | - | ($25.52M) | - | - | - | ($8.49M) |
| Financing Cash Flow | - | ($8.07M) | - | - | - | ($6.40M) | - | - | - | $71.99M |
| CapEx | - | $4.00M | - | - | - | $6.54M | - | - | - | $6.53M |
| Free Cash Flow | - | ($12.30M) | - | - | - | ($48.91M) | - | - | - | ($28.50M) |
Ratios
| Metric | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 | Q2 '21 | Q1 '21 | Q4 '20 | Q3 '20 | Q2 '20 | Q1 '20 |
|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | ||||||||||
| Gross margin | - | - | - | - | - | - | - | - | - | - |
| Operating margin | 6.7% | -1.0% | - | 8.9% | 7.2% | 0.9% | - | 5.1% | 16.6% | -3.9% |
| EBITDA margin | - | - | - | - | - | - | - | 7.8% | 19.7% | -0.8% |
| Net margin | 3.2% | -3.1% | - | 7.3% | 3.6% | -1.4% | - | 2.7% | 13.3% | -6.7% |
| Free cash flow margin | - | -4.7% | - | - | - | -20.6% | - | - | - | -12.2% |
| FCF / Net income | - | 1.54 | - | - | - | 14.69 | - | - | - | 1.81 |
| R&D / Revenue | - | - | - | - | - | - | - | - | - | - |
| SG&A / Revenue | 11.4% | 12.4% | - | 10.2% | 11.8% | 13.0% | - | 12.2% | 13.7% | 12.1% |
| Effective tax rate | 22.8% | - | - | -16.1% | 20.5% | - | - | -39.0% | -3.3% | - |
| Return on assets | 1.0% | -0.8% | - | 2.2% | 1.1% | -0.4% | - | 0.7% | 3.3% | -1.8% |
| Return on equity | 8.1% | -7.3% | - | 23.6% | 15.9% | -6.8% | - | 21.1% | 149.0% | 98.4% |
| Return on invested capital | - | - | - | - | - | - | - | - | - | - |
| Liquidity | ||||||||||
| Current ratio | 1.23 | 1.39 | 1.40 | 1.52 | 1.42 | 1.51 | 1.53 | 1.40 | 1.46 | 1.96 |
| Quick ratio | 0.85 | 0.98 | 1.02 | 1.12 | 1.04 | 1.11 | 1.22 | 1.11 | 1.18 | 1.57 |
| Cash ratio | 0.11 | 0.19 | 0.27 | 0.36 | 0.34 | 0.36 | 0.59 | 0.57 | 0.57 | 0.69 |
| Leverage | ||||||||||
| Debt / Equity | - | - | - | - | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest coverage | - | - | - | - | - | - | - | - | - | - |
| Equity multiplier | 7.72 | 8.84 | 9.06 | 10.53 | 14.58 | 18.17 | 18.65 | 29.49 | 44.61 | -54.32 |
| Liabilities / Assets | 0.87 | 0.89 | 0.89 | 0.91 | 0.93 | 0.94 | 0.95 | 0.97 | 0.98 | 1.02 |
| Efficiency | ||||||||||
| Asset turnover | 0.32 | 0.27 | - | 0.31 | 0.30 | 0.27 | - | 0.27 | 0.25 | 0.27 |
| Inventory turnover | - | - | - | - | - | - | - | - | - | - |
| Days sales outstanding | 177d | 195d | - | 171d | 162d | 182d | - | 173d | 181d | 201d |
| Days inventory outstanding | - | - | - | - | - | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - | - | - | - | - | - |
| Valuation | ||||||||||
| P / E | - | - | - | - | - | - | - | - | - | - |
| P / B | - | - | - | - | - | - | - | - | - | - |
| P / S | - | - | - | - | - | - | - | - | - | - |
| EV / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Growth | ||||||||||
| Revenue growth (YoY) | 11.1% | 10.0% | - | 12.9% | 20.3% | 1.6% | - | -8.2% | -17.0% | -1.1% |
| Revenue CAGR (3y) | 3.5% | 3.4% | - | 4.0% | 1.7% | 0.5% | - | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - | - | - | - | - | - |
| Operating income growth (YoY) | 3.4% | - | - | 96.3% | -48.3% | - | - | -24.9% | 68.2% | -363.5% |
| Net income growth (YoY) | -0.4% | -139.5% | - | 209.9% | -67.3% | 78.9% | - | 19.8% | 209.5% | -126.6% |
| EPS growth (YoY) | 0.0% | - | - | 200.0% | -67.9% | - | - | 20.0% | 211.5% | - |
| EPS CAGR (3y) | 0.0% | - | - | 65.1% | -9.4% | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| FCF growth (YoY) | - | 74.8% | - | - | - | -71.6% | - | - | - | 28.2% |
| FCF CAGR (5y) | - | - | - | - | - | - | - | - | - | - |
| Book value growth (YoY) | 96.0% | 120.4% | 116.1% | 177.1% | 206.5% | - | 436.4% | - | - | 47.7% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2021-12-31.
Business segments
$1.12B totalPatient Care Centers$943.33M · 84.2%
Products And Services$177.16M · 15.8%
Product / service
$1.12B totalCommercial Insurance Excluding Medicare And Medicaid Managed Care$327.84M · 29.3%
Medicare$296.33M · 26.4%
Medicaid$166.41M · 14.9%
Distribution Services Net Of Intersegment Revenue Eliminations$133.64M · 11.9%
Veterans Affairs$89.36M · 8.0%
Private Pay$63.40M · 5.7%
Therapeutic Solutions$43.52M · 3.9%
Peer comparison
Same SIC group: Services-Specialty Outpatient Facilities, NEC
Comparing HANGER against the 5 most active filers in the same SIC group.